Logo image of IROQ

IF BANCORP INC (IROQ) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:IROQ - US44951J1051 - Common Stock

26.2 USD
-0.05 (-0.19%)
Last: 12/12/2025, 8:00:02 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to IROQ. IROQ was compared to 386 industry peers in the Banks industry. Both the profitability and financial health of IROQ have multiple concerns. IROQ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year IROQ was profitable.
In the past year IROQ had a positive cash flow from operations.
IROQ had positive earnings in each of the past 5 years.
Each year in the past 5 years IROQ had a positive operating cash flow.
IROQ Yearly Net Income VS EBIT VS OCF VS FCFIROQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M 4M 6M 8M

1.2 Ratios

The Return On Assets of IROQ (0.59%) is worse than 73.32% of its industry peers.
The Return On Equity of IROQ (5.99%) is worse than 73.58% of its industry peers.
Industry RankSector Rank
ROA 0.59%
ROE 5.99%
ROIC N/A
ROA(3y)0.41%
ROA(5y)0.52%
ROE(3y)4.72%
ROE(5y)5.7%
ROIC(3y)N/A
ROIC(5y)N/A
IROQ Yearly ROA, ROE, ROICIROQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

1.3 Margins

IROQ's Profit Margin of 18.85% is on the low side compared to the rest of the industry. IROQ is outperformed by 68.91% of its industry peers.
IROQ's Profit Margin has declined in the last couple of years.
IROQ does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 18.85%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-7.07%
PM growth 5Y-1.91%
GM growth 3YN/A
GM growth 5YN/A
IROQ Yearly Profit, Operating, Gross MarginsIROQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1

2. Health

2.1 Basic Checks

IROQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IROQ remains at a similar level compared to 1 year ago.
Compared to 5 years ago, IROQ has more shares outstanding
The debt/assets ratio for IROQ has been reduced compared to a year ago.
IROQ Yearly Shares OutstandingIROQ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M
IROQ Yearly Total Debt VS Total AssetsIROQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

The Debt to FCF ratio of IROQ is 4.72, which is a neutral value as it means it would take IROQ, 4.72 years of fcf income to pay off all of its debts.
IROQ's Debt to FCF ratio of 4.72 is on the low side compared to the rest of the industry. IROQ is outperformed by 70.21% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that IROQ is not too dependend on debt financing.
IROQ has a Debt to Equity ratio of 0.21. This is in the lower half of the industry: IROQ underperforms 60.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 4.72
Altman-Z N/A
ROIC/WACCN/A
WACC16.18%
IROQ Yearly LT Debt VS Equity VS FCFIROQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
IROQ Yearly Current Assets VS Current LiabilitesIROQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

3

3. Growth

3.1 Past

IROQ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 158.38%, which is quite impressive.
Measured over the past 5 years, IROQ shows a small growth in Earnings Per Share. The EPS has been growing by 0.23% on average per year.
The Revenue has grown by 18.18% in the past year. This is quite good.
Measured over the past years, IROQ shows a small growth in Revenue. The Revenue has been growing by 2.20% on average per year.
EPS 1Y (TTM)158.38%
EPS 3Y-9.45%
EPS 5Y0.23%
EPS Q2Q%118.73%
Revenue 1Y (TTM)18.18%
Revenue growth 3Y-2.46%
Revenue growth 5Y2.2%
Sales Q2Q%16.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IROQ Yearly Revenue VS EstimatesIROQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.27, which indicates a correct valuation of IROQ.
IROQ's Price/Earnings ratio is a bit more expensive when compared to the industry. IROQ is more expensive than 72.28% of the companies in the same industry.
When comparing the Price/Earnings ratio of IROQ to the average of the S&P500 Index (26.54), we can say IROQ is valued slightly cheaper.
Industry RankSector Rank
PE 16.27
Fwd PE N/A
IROQ Price Earnings VS Forward Price EarningsIROQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

IROQ's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. IROQ is more expensive than 73.83% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.84
EV/EBITDA N/A
IROQ Per share dataIROQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)69.41
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

IROQ has a Yearly Dividend Yield of 1.52%.
IROQ's Dividend Yield is slightly below the industry average, which is at 2.87.
IROQ's Dividend Yield is slightly below the S&P500 average, which is at 1.96.
Industry RankSector Rank
Dividend Yield 1.52%

5.2 History

The dividend of IROQ is nicely growing with an annual growth rate of 6.77%!
IROQ has been paying a dividend for at least 10 years, so it has a reliable track record.
IROQ has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)6.77%
Div Incr Years9
Div Non Decr Years11
IROQ Yearly Dividends per shareIROQ Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

IROQ pays out 25.40% of its income as dividend. This is a sustainable payout ratio.
IROQ's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP25.4%
EPS Next 2YN/A
EPS Next 3YN/A
IROQ Yearly Income VS Free CF VS DividendIROQ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M 4M 6M 8M
IROQ Dividend Payout.IROQ Dividend Payout, showing the Payout Ratio.IROQ Dividend Payout.PayoutRetained Earnings

IF BANCORP INC

NASDAQ:IROQ (12/12/2025, 8:00:02 PM)

26.2

-0.05 (-0.19%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-30 2025-10-30
Earnings (Next)01-28 2026-01-28
Inst Owners31.27%
Inst Owner Change2.91%
Ins Owners18.7%
Ins Owner Change0%
Market Cap87.77M
Revenue(TTM)26.85M
Net Income(TTM)5.06M
Analysts0
Price TargetN/A
Short Float %0.11%
Short Ratio0.42
Dividend
Industry RankSector Rank
Dividend Yield 1.52%
Yearly Dividend0.38
Dividend Growth(5Y)6.77%
DP25.4%
Div Incr Years9
Div Non Decr Years11
Ex-Date09-26 2025-09-26 (0.2)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.27
Fwd PE N/A
P/S 3.27
P/FCF 22.84
P/OCF 21.64
P/B 1.04
P/tB 1.06
EV/EBITDA N/A
EPS(TTM)1.61
EY6.15%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.15
FCFY4.38%
OCF(TTM)1.21
OCFY4.62%
SpS8.02
BVpS25.23
TBVpS24.8
PEG (NY)N/A
PEG (5Y)69.41
Graham Number30.23
Profitability
Industry RankSector Rank
ROA 0.59%
ROE 5.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 18.85%
GM N/A
FCFM 14.31%
ROA(3y)0.41%
ROA(5y)0.52%
ROE(3y)4.72%
ROE(5y)5.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-7.07%
PM growth 5Y-1.91%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 4.72
Debt/EBITDA N/A
Cap/Depr 34.03%
Cap/Sales 0.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 75.9%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC16.18%
ROIC/WACCN/A
Cap/Depr(3y)138.9%
Cap/Depr(5y)103.04%
Cap/Sales(3y)3.56%
Cap/Sales(5y)2.63%
Profit Quality(3y)92.12%
Profit Quality(5y)108.56%
High Growth Momentum
Growth
EPS 1Y (TTM)158.38%
EPS 3Y-9.45%
EPS 5Y0.23%
EPS Q2Q%118.73%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.18%
Revenue growth 3Y-2.46%
Revenue growth 5Y2.2%
Sales Q2Q%16.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y119.6%
FCF growth 3Y-7.66%
FCF growth 5Y-0.66%
OCF growth 1Y-0.1%
OCF growth 3Y-7.96%
OCF growth 5Y-0.41%

IF BANCORP INC / IROQ FAQ

What is the ChartMill fundamental rating of IF BANCORP INC (IROQ) stock?

ChartMill assigns a fundamental rating of 2 / 10 to IROQ.


What is the valuation status for IROQ stock?

ChartMill assigns a valuation rating of 1 / 10 to IF BANCORP INC (IROQ). This can be considered as Overvalued.


How profitable is IF BANCORP INC (IROQ) stock?

IF BANCORP INC (IROQ) has a profitability rating of 2 / 10.


How financially healthy is IF BANCORP INC?

The financial health rating of IF BANCORP INC (IROQ) is 2 / 10.